Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | IDO1 | P14902 | 4/20 | 0.36 |
| ▸ | HTR3E | A5X5Y0 | 2/20 | 0.36 |
| ▸ | HTR3B | O95264 | 2/20 | 0.36 |
| ▸ | HTR3A | P46098 | 2/20 | 0.36 |
| ▸ | HTR3D | Q70Z44 | 2/20 | 0.36 |
| ▸ | HTR3C | Q8WXA8 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | GFER | P55789 | 1/20 | 0.33 |
| ▸ | CHIA | Q9BZP6 | 1/20 | 0.33 |
| ▸ | SLC22A2 | O15244 | 1/20 | 0.32 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.32 |
| ▸ | SLC22A3 | O75751 | 1/20 | 0.32 |
| ▸ | PLAU | P00749 | 1/20 | 0.32 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8854244 | 0.90 | KMT2A (0.31) | IDO1MAPTKMT2ATDP1MAPK1 | |
| SCHEMBL4259665 | 0.80 | KMT2A (0.40) | LMNAIDO1HTR3EHTR3BHTR3A | |
| SCHEMBL11173933 | 0.73 | GAA (0.43) | LMNAALDH1A1MAPTKMT2ATDP1 | |
| SCHEMBL16679452 | 0.73 | MAPT (0.41) | ALDH1A1MAPTKMT2ATDP1GAA | |
| SCHEMBL3392509 | 0.73 | LMNA (0.48) | LMNAIDO1HTR3EHTR3BHTR3A | |
| SCHEMBL27717908 | 0.71 | LMNA (0.46) | LMNAIDO1HTR3EHTR3BHTR3A | |
| SCHEMBL11635936 | 0.71 | LMNA (0.46) | LMNAIDO1HTR3EHTR3BHTR3A | |
| SCHEMBL2418864 | 0.70 | ALDH1A1 (0.36) | LMNAIDO1HTR3EHTR3BHTR3A | |
| SCHEMBL14058840 | 0.68 | LMNA (0.43) | LMNAIDO1HTR3EHTR3BHTR3A | |
| SCHEMBL28527559 | 0.68 | ALDH1A1 (0.42) | LMNAIDO1HTR3EHTR3BHTR3A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111979114-A | Black cattle epidemic prevention inspection kit and preparation method thereof | 潍坊友容实业有限公司 | 2020-11-24 | — | — | CN | claimed |
| CN-114173560-B | Articles comprising crosslinked guanidine-containing polymers and uses thereof | 舒万诺知识产权公司 | 2024-07-09 | — | — | CN | disclosed |
| US-20240024205-A1 | DENTAL RETRACTION COMPOSITION | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY | 2024-01-25 | — | — | US | disclosed |
| US-11827864-B2 | Wipe with a guanidinyl-containing polymer | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2023-11-28 | — | — | US | disclosed |
| US-11766386-B2 | Medical composition containing guanidinyl-containing polymer(s) and carrageenane(s) | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2023-09-26 | — | — | US | disclosed |
| US-20230100885-A1 | WIPE WITH A GUANIDINYL-CONTAINING POLYMER | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY | 2023-03-30 | — | — | US | disclosed |
| US-11576845-B2 | Methods of removing spores comprising alcohol, acrylate copolymer particles, and a cationic coated article | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2023-02-14 | — | — | US | disclosed |
| US-11572341-B2 | Biguanide compound and use thereof | IMMUNOMET THERAPEUTICS INC. (US) | 2023-02-07 | — | — | US | disclosed |
| US-20220241458-A1 | Removable Film-Forming Gel Compositions Featuring Adhesion Promoters | KINDEVA DRUG DELIVERY L.P. (US) | 2022-08-04 | — | — | US | disclosed |
| CN-114173560-A | Article comprising crosslinked guanidino-containing polymers and uses thereof | 3M创新有限公司 | 2022-03-11 | — | — | CN | disclosed |
| US-20160115430-A1 | WIPE WITH A GUANIDINYL-CONTAINING POLYMER | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY | 2016-04-28 | — | — | US | disclosed |
| EP-2889625-A1 | LIGAND GUANIDINYL FUNCTIONALIZED POLYMERS | 3M Innovative Properties Company (US) | 2015-07-01 | — | — | EP | disclosed |
| EP-2542889-B1 | LIGAND GUANIDINYL FUNCTIONALIZED POLYMERS | 3M INNOVATIVE PROPERTIES CO (US) | 2015-03-25 | — | — | EP | disclosed |
| US-20130224825-A1 | LIGAND FUNCTIONALIZED POLYMERS | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2013-08-29 | — | — | US | disclosed |
| US-20130217032-A1 | LIGAND FUNCTIONALIZED POLYMERS | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2013-08-22 | — | — | US | disclosed |
| US-8435776-B2 | Ligand functionalized polymers | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2013-05-07 | — | — | US | disclosed |
| US-20110263901-A1 | Process of Preparation of Proguanil | USV LTD. (IN) | 2011-10-27 | — | — | US | disclosed |
| US-20110217752-A1 | LIGAND FUNCTIONALIZED POLYMERS | 3M INNOVATIVE PROPERTIES COMPANY | 2011-09-08 | — | — | US | disclosed |
| EP-2150528-A2 | PROCESS FOR PREPARATION OF PROGUANIL HYDROCHLORIDE | USV Limited (IN) | 2010-02-10 | — | — | EP | disclosed |
| WO-2009113092-A2 | PROCESS FOR PREPARATION OF PROGUANIL HYDROCHLORIDE | USV LIMITED (IN) | 2009-09-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240024205-A1 | DENTAL RETRACTION COMPOSITION | GK, GANC, JMJD1C | LMNA 1790/4885IDO1 4592/4885HTR3E 4426/4885 |
| US-11766386-B2 | Medical composition containing guanidinyl-containing polymer(s) and carrageenane(s) | GANC, GMPS, MGAM | LMNA 3606/4885IDO1 4515/4885HTR3E 2723/4885 |
| US-11576845-B2 | Methods of removing spores comprising alcohol, acrylate copolymer particles, and a cationic coated article | ACR, CUTA, PRKDC | LMNA 1262/4885IDO1 3924/4885HTR3E 1559/4885 |
| US-11572341-B2 | Biguanide compound and use thereof | MKI67, GCG, GCKR | LMNA 3013/4885IDO1 2577/4885HTR3E 3330/4885 |
| US-20110263901-A1 | Process of Preparation of Proguanil | GCG, PREP, G6PD | LMNA 80/4885IDO1 806/4885HTR3E 1857/4885 |
| US-11827864-B2 | Wipe with a guanidinyl-containing polymer | GNPDA1, GDA, PGLS | LMNA 3599/4885IDO1 1324/4885HTR3E 3112/4885 |
| US-20130224825-A1 | LIGAND FUNCTIONALIZED POLYMERS | SELPLG, CD69, SIGLEC7 | LMNA 3067/4885IDO1 2843/4885HTR3E 1411/4885 |
| US-20110217752-A1 | LIGAND FUNCTIONALIZED POLYMERS | SELPLG, CD69, SIGLEC7 | LMNA 3067/4885IDO1 2843/4885HTR3E 1411/4885 |
| US-20230100885-A1 | WIPE WITH A GUANIDINYL-CONTAINING POLYMER | GNPDA1, GDA, PGLS | LMNA 3599/4885IDO1 1324/4885HTR3E 3112/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.